Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantifying the early stages of remyelination following cuprizone-induced demyelination.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
GlaxoSmithKline Protocol Summaries: Firategrast
Episode 22 with Dr. Paul Matthews discussing the Optimize project in the UK
Seeing illness in art and medicine: a patient and printmaker collaboration.
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Keystone Symposium: Gut Microbiota Modulation of Host Physiology: The Search for Mechanism
Immunopathogenesis of neuromyelitis optica.
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Sex differences in autoimmune diseases.
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Pregnancy and multiple sclerosis.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
National MS Society: Sylvia Lawry Physician Fellowships
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Teriflunomide modest help but safe for MS
American Academy of Neurology: Breakthroughs in Neurology
Experimental models of spontaneous autoimmune disease in the central nervous system.
Best practice in the use of natalizumab in multiple sclerosis.
The neuroendocrine axis in patients with multiple sclerosis.
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with MS.

Pages